Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Risk Saf Med ; 33(1): 23-26, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-33967060

RESUMO

BACKGROUND: Pheniramine abuse is reported not only in patients with psychiatric disorders but also in the general population. CASE REPORT: We report a case of pheniramine dependence in a patient with obsessive-compulsive disorder. The patient took about 250 mg orally daily and injected about 90 mg every week from the last six months. It reduced his anxiety, was cheaper than his other psychiatric medications, and free of stigma. He had lethargy, headache, uneasiness, anxiety, and poor sleep as withdrawal symptoms. RESULTS: This case highlights the vulnerability of those with psychiatric disorders towards pheniramine abuse. Hence, this report advocates the strict evaluation of over-the-counter drugs for patients with pre-existing psychiatric disorders.


Assuntos
Transtorno Obsessivo-Compulsivo , Síndrome de Abstinência a Substâncias , Ansiedade , Transtornos de Ansiedade/induzido quimicamente , Transtornos de Ansiedade/diagnóstico , Humanos , Transtorno Obsessivo-Compulsivo/diagnóstico , Transtorno Obsessivo-Compulsivo/tratamento farmacológico , Transtorno Obsessivo-Compulsivo/epidemiologia , Feniramina/efeitos adversos
2.
Dermatol Online J ; 24(6)2018 08 23.
Artigo em Inglês | MEDLINE | ID: mdl-30142724

RESUMO

Fixed drug eruption is a delayed type hypersensitivity reaction to a drug seen most frequently with antibiotics such as tetracyclines, sulfonamides, and NSAIDs such as naproxen and ibuprofen. Although H1-antihistamines rarely elicit cutaneous adverse effects, there have been a few reports in the literature implicating them in causing fixed drug eruption, particularly the piperazine derivatives (hydroxyzine, cetirizine, levocetirizine), and loratadine. However, cutaneous drug reactions with the alkylamine derivatives like pheniramine maleate are extremely uncommon and fixed drug eruptions have not been reported with any of the alkylamine antihistamines to date. We herein report a case of multifocal bullous fixed drug eruption following ingestion of pheniramine maleate.


Assuntos
Erupção por Droga/etiologia , Antagonistas dos Receptores Histamínicos H1/efeitos adversos , Feniramina/efeitos adversos , Infecções Respiratórias/tratamento farmacológico , Dermatopatias Vesiculobolhosas/induzido quimicamente , Adulto , Erupção por Droga/tratamento farmacológico , Erupção por Droga/patologia , Feminino , Glucocorticoides/administração & dosagem , Antagonistas dos Receptores Histamínicos H1/uso terapêutico , Humanos , Feniramina/uso terapêutico , Dermatopatias Vesiculobolhosas/tratamento farmacológico , Dermatopatias Vesiculobolhosas/patologia
4.
Int Ophthalmol ; 38(4): 1775-1778, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28669099

RESUMO

Most of the rare bilateral acute angle closure (AAC) cases are precipitated by systemic factors, such as drug intake, snake bite or general anaesthesia. We present a case of simultaneous bilateral AAC in a middle-aged male, precipitated by the use of medication for flu, containing an alpha-1 adrenergic receptor agonist and an anticholinergic agent. In our case, axial length was shorter, anterior chamber depth was narrower, and the lens was thicker than normal, including the patient within the risk group for AAC. In this circumstance, drugs acted as triggers. Case description and evolution following treatment are completed with the discussion of mechanisms involved in triggering bilateral AAC in predisposed patients, as emerging from literature. This case report brings up the risk of bilateral AAC in patients at risk, of which ophthalmologists, physicians of other specialties and patients should be aware of.


Assuntos
Acetaminofen/efeitos adversos , Agonistas de Receptores Adrenérgicos alfa 1/efeitos adversos , Antagonistas Colinérgicos/efeitos adversos , Glaucoma de Ângulo Fechado/induzido quimicamente , Antagonistas dos Receptores Histamínicos H1/efeitos adversos , Feniramina/efeitos adversos , Fenilefrina/efeitos adversos , Humanos , Masculino , Pessoa de Meia-Idade
5.
Int J Risk Saf Med ; 27(3): 153-7, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26410249

RESUMO

Excessive use of over-the-counter (OTC) medications has been a growing public health problem. We present the case of a patient with avoidant personality disorder, social phobia, and dull normal intelligence, with dependence to pheniramine maleate. His anxiety symptoms, initially unresponsive to conventional treatment, reduced only after stopping pheniramine during inpatient care. This case emphasizes the need for awareness and regular monitoring of the use of OTC medications in vulnerable patient populations.


Assuntos
Transtornos da Personalidade/complicações , Transtornos da Personalidade/fisiopatologia , Feniramina/administração & dosagem , Feniramina/efeitos adversos , Transtornos Relacionados ao Uso de Substâncias/etiologia , Adulto , Humanos , Masculino
9.
Subst Abus ; 26(1): 45-7, 2005 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16492663

RESUMO

Abuse and addiction of histaminergic agonists and antagonists were investigated. The withdrawal signs may become after using drugs such as L-histidine, histamine-N-methyl, promethazine, pheniramine, astemizole, etc. Some medicines which include these active metabolites could lead to dependence cause different side effects. This case suggests that pheniramine abuse also could to dependence. We should pay attention to trend of pheniramine and other histaminergic drugs dependence and need to regulate the market by law more severely.


Assuntos
Antialérgicos , Antagonistas dos Receptores Histamínicos H1 , Feniramina , Transtornos Relacionados ao Uso de Substâncias/diagnóstico , Adulto , Antialérgicos/administração & dosagem , Antialérgicos/efeitos adversos , Relação Dose-Resposta a Droga , Feminino , Antagonistas dos Receptores Histamínicos H1/administração & dosagem , Antagonistas dos Receptores Histamínicos H1/efeitos adversos , Humanos , Feniramina/administração & dosagem , Feniramina/efeitos adversos , Automedicação , Distúrbios do Início e da Manutenção do Sono/tratamento farmacológico , Distúrbios do Início e da Manutenção do Sono/psicologia , Síndrome de Abstinência a Substâncias/diagnóstico , Síndrome de Abstinência a Substâncias/psicologia , Transtornos Relacionados ao Uso de Substâncias/psicologia
11.
Aviat Space Environ Med ; 68(11): 1035-7, 1997 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9383505

RESUMO

The use of topical ocular antihistamine/decongestant combinations to treat symptoms associated with allergic conjunctivitis is widespread, effective, and generally without adverse effects. Recently, these medications have become available without a prescription, possibly leading patients to the erroneous assumption that they are void of side effects. Likewise, patients may use these drugs for many ocular therapies for which they are unintended, possibly resulting in ocular complications. One significant adverse effect of these antihistamine/decongestant combinations when used inappropriately is pupillary dilation with associated blurry vision. Continued emphasis of the possible deleterious side effects by the clinician is recommended to circumvent these problems.


Assuntos
Conjuntivite Alérgica/tratamento farmacológico , Lentes de Contato Hidrofílicas/efeitos adversos , Antagonistas dos Receptores Histamínicos H1/efeitos adversos , Midríase/induzido quimicamente , Nafazolina/efeitos adversos , Descongestionantes Nasais/efeitos adversos , Medicamentos sem Prescrição/efeitos adversos , Feniramina/efeitos adversos , Adulto , Combinação de Medicamentos , Humanos , Masculino , Soluções Oftálmicas
12.
Drugs Exp Clin Res ; 17(8): 399-403, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-1688044

RESUMO

A controlled and completely randomized study was carried out with the aim of assessing the efficacy and safety of oxatomide gel in comparison with another preparation for topical use, dechlorpheniramine. Twenty-seven patients (sixteen F, eleven M) aged between 21 and 72 years (mean age 39) suffering from chronic idiopathic urticaria were treated for 15 days with oxatomide gel at 5% or dechlorpheniramine cream at 1%; 15 days of follow-up without therapy were then observed. Both the treatments allowed significant control of cutaneous symptoms. In particular, in the group treated with oxatomide there was a more marked reduction in itching and in the number of weals (p less than 0.01 between times), and in the dechlorpheniramine group in the severity of erythema (p less than 0.01 between times). During the follow-up period, a distinct flare-up of symptoms was observed only in the dechlorpheniramine group. Acceptability and safety, both clinical and biological, were good for both products.


Assuntos
Antagonistas dos Receptores Histamínicos H1/administração & dosagem , Feniramina/administração & dosagem , Piperazinas/administração & dosagem , Urticária/tratamento farmacológico , Administração Tópica , Adulto , Idoso , Eritema/tratamento farmacológico , Feminino , Géis , Antagonistas dos Receptores Histamínicos H1/efeitos adversos , Humanos , Masculino , Pessoa de Meia-Idade , Pomadas , Feniramina/efeitos adversos , Piperazinas/efeitos adversos , Prurido/tratamento farmacológico , Urticária/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...